Add Yahoo as a preferred source to see more of our stories on Google. In a large clinical trial assessing Apretude, ViiV Healthcare’s recently approved injectable drug, as a form of HIV prevention, ...

Add Yahoo as a preferred source to see more of our stories on Google. A groundbreaking annual injection designed to protect against Human Immunodeficiency Virus (HIV) has successfully passed an ...

Young men who have sex with men (YMSM) said the treatment’s efficacy was the most important feature injectable HIV pre-exposure prophylaxis (PrEP), over side effects, cost, protection duration, and ...

Michael Montess receives funding from the Canadian Institutes of Health Research, Mitacs, the Social Sciences and Humanities Research Council, and the Michael Smith Foundation for Health Research. He ...

Rwanda's nationwide rollout of long-acting injectable PrEP, Cabotegravir, marks a significant step forward in the fight against HIV/AIDS. However, this development highlights a deeper truth: ending ...

A nurse at Tudor Sub-County Hospital in Mombasa administers Lenacapavir injection during the rollout of the vaccine on March 13, 2026. [Robert Menza, Standard] Mombasa County has officially rolled out ...

The government is set to begin a nationwide rollout of a long-acting HIV prevention injection, Cabotegravir (CAB-LA), this week, following a successful one-year pilot phase.The rollout aims to provide ...

A recent study of injectable pre-exposure prophylaxis found that twice-yearly injections of lenacapavir — marketed as Yeztugo by Gilead Sciences — do not have clinically significant interactions with ...

The burden of taking a daily dose of PrEP might soon be lifted. According to updated CDC guidelines, bi-monthly injectable PrEP is expected to receive FDA approval by February. The injectable ...

The US Food and Drug Administration has approved the first injectable medication for pre-exposure prophylaxis (PrEP) to lower the risk of getting HIV through sex, it announced Monday. Apretude is ...